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Abstract
Leishmania mexicana (Lm) causes localized (LCL) and diffuse (DCL) cutaneous leishmaniasis. DCL patients have a poor
cellular immune response leading to chronicity. It has been proposed that CD8 T lymphocytes (CD8) play a crucial role in
infection clearance, although the role of CD8 cytotoxicity in disease control has not been elucidated. Lesions of DCL patients
have been shown to harbor low numbers of CD8, as compared to patients with LCL, and leishmanicidal treatment restores
CD8 numbers. The marked response of CD8 towards Leishmania parasites led us to analyze possible functional differences
between CD8 from patients with LCL and DCL. We compared IFNc production, antigen-specific proliferation, and
cytotoxicity of CD8 purified from PBMC against autologous macrophages (MO) infected with Leishmania mexicana (MOi).
Additionally, we analyzed tissue biopsies from both groups of patients for evidence of cytotoxicity associated with
apoptotic cells in the lesions. We found that CD8 cell of DCL patients exhibited low cytotoxicity, low antigen-specific
proliferation and low IFNc production when stimulated with MOi, as compared to LCL patients. Additionally, DCL patients
had significantly less TUNEL
+ cells in their lesions. These characteristics are similar to cellular ‘‘exhaustion’’ described in
chronic infections. We intended to restore the functional capacity of CD8 cells of DCL patients by preincubating them with
TLR2 agonists: Lm lipophosphoglycan (LPG) or Pam3Cys. Cytotoxicity against MOi, antigen-specific proliferation and IFNc
production were restored with both stimuli, whereas PD-1 (a molecule associated with cellular exhaustion) expression, was
reduced. Our work suggests that CD8 response is associated with control of Lm infection in LCL patients and that chronic
infection in DCL patients leads to a state of CD8 functional exhaustion, which could facilitate disease spread. This is the first
report that shows the presence of functionally exhausted CD8 T lymphocytes in DCL patients and, additionally, that pre-
stimulation with TLR2 ligands can restore the effector mechanisms of CD8 T lymphocytes from DCL patients against
Leishmania mexicana-infected macrophages.
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Introduction
Leishmaniasis is a zoonotic disease that infects humans as well
as a variety of mammalian species. Several Leishmania species, such
as L. mexicana, L. amazonensis, L. braziliensis and L. aethiopica can
cause two opposite clinical forms of cutaneous leishmaniasis:
localized cutaneous leishmaniasis (LCL) and diffuse cutaneous
leishmaniasis (DCL) [1]. While the former is relatively benign,
consisting of a single ulcer that forms at the infection site, patients
with DCL have a continuous uncontrolled spread of the parasite
throughout the skin and, in advanced stages, these patients also
show parasite invasion of the oro- and nasopharygeal mucosae.
Although the prevalence of DCL patients in Mexico is low, they
represent a public health problem for which no successful cure has
been found. These patients lack an effective T cell immune
response capable of activating MOi, and antimonial treatment
only achieves transitory remission [2, 3 and 4].
Murine models infected with L. major have shown that both the
innate and acquired immune responses are necessary for parasite
clearance. Cells such as MO, dendritic cells, NK cells, CD8 and
CD4 T lymphocytes; cytokines such as interleukin (IL)-12 and
interferon gamma (IFNc), pattern recognition receptors such as
Toll like receptors (TLRs) [6,7,8] and effector molecules such as
nitric oxide (NO) and superoxide anion (O2
-) [9] have been
reported to mediate protection, both in mouse models and in
humans. It has also been proposed that CD8 T cells play a crucial
www.plosntds.org 1 November 2010 | Volume 4 | Issue 11 | e871role in infection clearance, although the role of CD8 cytotoxicity
in disease control has not been elucidated. Elevated numbers of
CD8 have been reported in blood and lesions of patients infected
with L. major and L. mexicana and their protective role has been
associated with IFNc production [10]. Additionally, we have
previously reported that the number of CD8 is importantly
reduced in lesions of DCL patients infected with L. mexicana,a s
compared to LCL patients [11]. Thus, a comparative analysis of
the overall immune effector functions of CD8 from LCL and DCL
patients would permit a more precise definition of the role played
by these cells in the disease outcome, both by their cytokine
production as well as by their cytotoxicity. We here report a
functional analysis of CD8 isolated from peripheral blood of LCL
and DCL patients infected with Leishmania mexicana. Our results
show significant differences between CD8 of both groups: while
CD8 from LCL patients produce high levels of IFNc and show
cytotoxicity against autologous MOi, the CD8 from DCL patients
show a diminished response both in cytokine production as well in
Leishmania-specific cytotoxicity. Thereafter we analyzed if the
differential cytotoxicity observed in vitro also correlated with the
number of apoptotic cells in lesions of both groups of patients and
found that DCL patients have significantly less TUNEL
+ cells than
LCL patients. The diminished CD8 response in DCL patients
resembled the cellular ‘‘exhaustion’’ reported for CD8 in other
chronic diseases [12,13,14,15], where CD8-effector capacity could
be restored by different mechanisms including TLR signaling
[16,17,18]. Since TLR2 signaling in CD8 enhanced proliferation
and survival in vitro [19], we analyzed whether TLR2 stimulation
of CD8 from DCL patients could also restore their functional
capacity. We therefore stimulated CD8 from DCL patients with
the TLR2-specific agonist Pam3Cys and with Leishmania mexicana
LPG, which has been shown to be a TLR2 ligand capable of
activating human peripheral blood mononuclear cells and NK
cells to produce Th1-promoting cytokines [6,8]. We show that
stimulation with TLR2-specific agonists Pam3CyS or with
Leishmania LPG can restore the effector functions of CD8 from
DCL patients, including IFNc production, antigen specific cellular
proliferation and cytotoxicity against MOi. In addition to restoring
these functions, TLR2-stimulated CD8 cells showed a reduction in
PD-1 expression, a molecule frequently present in cellular
exhaustion. This phenomenon had previously been described
with the TLR9 ligand CpG ODN in mice [18].
Materials and Methods
Patients
Human experimentation guidelines of the Mexican Health
authorities were strictly followed. The study was reviewed and
approved by the Ethics Research Committee of the Medical
Faculty of UNAM. Written informed consent was required for all
patients. Ten individuals with LCL (4 females and 6 males, mean
age=34.6613.9) and four with DCL (1 female and 3 males, mean
age=46612.9) from La Chontalpa – Tabasco State (except one
DCL), an endemic area in southeastern Mexico, were analyzed.
Patients were diagnosed by clinical criteria, parasite presence in
lesions, and immunoreactivity to the Montenegro skin test. LCL
patients showed skin ulcers containing few parasites and all were
positive to the Montenegro test. In contrast, DCL patients had
multiple non-ulcerative nodules, harboring an intense parasite
load and all were negative in the Montenegro test.
Peripheral blood for in vitro experiments was collected in tubes
with EDTA (BD Biosciences). Skin biopsy specimens were taken
from the lesions with a 4 mm biopsy punch (Stiefel Laboratories,
Inc., Coral Gables, FL) after local anesthesia (2% xylocaine). The
biopsy specimens were embedded in OCT compound (Miles
Scientific, Napperville, IL), snap frozen and stored in liquid
nitrogen until examined. All patients received antimonial therapy
after sample collection.
Immunohistochemistry
Frozen sections were cut with a cryostat and air-dried overnight
before the immunostaining procedure. Apoptotic cells in lesions of
7 LCL and 5 DCL patients were detected by the TUNEL method
(In Situ Cell Death Detection Kit, POD, Roche). Briefly, cryostat
sections (4 mm) were thawed onto coated slides, fixed in
paraformaldehyde 4% in PBS pH 7.4 for 20 min, washed
30 min with PBS and incubated with permeabilization solution
for 2 min on ice. Slides were rinsed twice with PBS and 50 ml
TUNEL reaction mixture were added to the tissue sections and
incubated for 60 min at 37uC in a humidified atmosphere in the
dark. Slides were washed 3 times with PBS and incubated with
50 ml of Converter-POD (Anti-fluorescein antibody conjugated
with horse-radish peroxidase) in a humidified chamber for 30 min
at 37uC. Slides were washed 3 times with PBS and incubated with
50 ml of DAB substrate for 10 min at 25uC and washed 3 times
with PBS. Then, samples were mounted under glass coverslips and
analyzed under light microscope. Double staining with anti-CD8
antibodies was carried out in six samples of LCL patients as
follows: after TUNEL staining, slides were washed with 100 mM
Tris-HCl, pH 7.4, 150 mM NaCl. The samples were blocked with
Blotto (a solution containing 5% skim milk powder and 0.1%
Tween 20 in PBS, pH 7.4) for 30 min at RT. The samples were
incubated with primary mouse anti-CD68 (1:100; Dako: Dako
Corp., Santa Barbara, CA) during 1 h in a humid chamber at RT.
Five-minute washes with 10 mM Tris-HCl, pH 7.4, 150 mM
NaCl were followed by 1 h incubation with biotin-conjugated
second-step antibody (goat anti-mouse IgG) at a dilution of 1:50
and with the preformed streptavidin-biotin alkaline phosphatase
complex (Dako) for 1 h at RT. The presence of alkaline
phosphatase was evidenced by incubation in AP substrate solution
containing 1 mM levamisole for 30 min. Then, slides were washed
twice in distilled water. Counterstaining was performed with H&E
Author Summary
Leishmania mexicana causes localized and diffuse cutane-
ous leishmaniasis. Whereas the former is a benign form the
disease, diffuse cutaneous leishmaniasis is a chronic
disfiguring disease, for which no cure is available, and
the immune cells of these patients respond poorly to the
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Leishmania-infected cells by CD8 T cells is crucial for
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benign form of the disease. We were able to restore
functional capacity of these cells by culturing them with
molecules that stimulate TLR2. This is the first report
showing that stimulation of the TLR2 can restore effector
mechanisms in functionally exhausted CD8 cells from
patients with diffuse cutaneous leishmaniasis. This finding
will help design novel treatment schemes for patients
infected with the parasite Leishmania mexicana who have
the progressive, incurable form of diffuse cutaneous
leishmaniasis.
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brown color, whereas MO showed red staining.
Leishmania mexicana culture
Leishmania mexicana (MHOM/MX/92/UADY/68) promasti-
gotes were grown in RPMI-1640 medium (Life Technologies
Laboratories, Gaithersburg, MA, USA) supplemented with 5%
heat-inactivated FBS at 28uC. Parasites were sub-cultured every 4
to 5 days and grown to a density of 1610
6/ml. Promastigotes were
harvested from stationary-phase cultures, centrifuged at 3500 rpm
for 10 min, washed three times in PBS, and finally counted after
immobilization with glycerol.
CD8 and MO purification
Peripheral blood mononuclear cells were separated by Ficoll-
Hypaque gradient (Sigma) and CD8 were isolated by magnetic cell
sorting system as described by manufacture’ instructions (Miltenyi
Biotec, Bergisch Gladbach, Germany). Briefly, 1610
7 PBMC was
suspended in 40 ml PBS containing 10 ml of anti-CD8 microbeads
and incubated for 30 min at 4uC. The cells were washed with PBS
and centrifuged at 1500 rpm for 10 min. They were then passed
through the LS separation columns (Miltenyi) placed in magnetic
field. The positive fraction was cultured in RPMI/FBS 10%. The
negative fraction was processed again in order to purify MO
(1610
7 cells in 40 ml of PBS with 10 ml of anti-CD14 microbeads).
MO were cultured in RPMI/FBS 10%. Both CD8 and MO were
maintained at 37uC in a humidified atmosphere containing 5%
CO2 incubator for 12 h before stimulus in order to reach a resting
condition.
MO infection
1610
6 MO were co-incubated with 1610
7 L. mexicana
promastigotes for 3 h at 28uC in 1 ml RPMI. Afterwards, cells
were cultured for additional 18 h at 37uC. Non-ingested
promastigotes were washed away with RPMI.
Cytotoxicity assay
The cytotoxicity of CD8 cells on MOi was analyzed by two
methods:
51Cr-release and Flow cytometry. The optimal CD8/
MOi ratio was established as 10/1.
51Cr-release assay. The assay was performed as previously
described [20]. Briefly, MO or MOi were labeled with 100 mCi of
51Cr (Perkin Elmer) for 1 h at 37uC, 5% CO2. The labeled cells
were washed twice in RPMI, suspended in RPMI and 1610
6 CD8
were co-incubated with autologous 1610
5 MOi. Co-cultures were
set up in 24 well flat bottom plates (Linbro, Aliso Viejo, CA) and
plates were incubated in triplicate for 4 h at 37uCi n5 %C O 2.
Controls included MOi incubated in medium alone for
spontaneous release and MOi incubated in 5% (v/v) Triton X-
100 (Sigma, St. Louis, MO) in PBS for maximum release.
Radioactivity was measured by Wallac Wizard1470 Automatic
Gamma Counter. The cytotoxicity percentage was calculated
using the formula: % cytotoxicity = (sample cpm – spontaneous
cpm) / (maximal cpm – spontaneous cpm) 6100%.
Flow cytometric assay. The assay was performed as
previously described [21]. Briefly, 1610
6 CD8 were mixed with
autologous 1610
5 MOi or MO in 24 well clear flat bottom ultra
low attachment plates and incubated at 37uC with 5% CO2 for
4 h. After incubation, 5 ml of Ab anti-CD14 PE (BD: Becton
Dickinson Biosciences, San Jose CA) were added for 15 min at
4uC. Afterwards, 10 mlo fa5mg/ml solution of 7-AAD (Sigma)
diluted in Annexin Binding buffer 16from 106concentrate (BD),
and 5 ml of annexin V-FITC (BD) were added to the cell
suspension for 10 min on ice. Samples were analyzed on a
FACSCanto II flow cytometer (BD). A minimum of 20 000 events
were collected and analyzed with DIVA software from the
instrument manufacturer. The cytotoxicity index (C.I). was
calculated using the formula: C.I. = {(CD14
+ annexin V
+)o f
CD8 incubated with MOi} – {(CD14
+ annexin V
+) of CD8
incubated with MO}.
In a parallel experiment, the expressions of FasL and Granzyme
B were evaluated using Ab anti-FasL – PE (BD) and anti-
granzyme – Alexa Fluor 647 (BD). The supernatant was harvested
for IFNc detection by means of ELISA test.
Proliferation assay
The proliferation of CD8 in response to autologous MOi was
analyzed as previously described [22]. Briefly, PBMC were
suspended in RPMI with CFDA (Sigma) [5 mM] during 10 min
at 37uC and washed twice in RPMI. Cells were cultured at 1610
6
per ml and 2610
5 MOi were added. MO or Con A [5 mg/ml]
(Sigma) were used as controls. The cells were co- cultured for 7
days at 37uC. Cells were harvested and incubated in the presence
of anti-CD3 CyChrome and anti-CD8 PE (BD). Stained samples
were fixed with 2% paraformaldehyde in PBS, and analyzed by
multicolor flow cytometry immediately after the end of the
incubation period. The percentage of CD3
+CD8
+CFDA
low was
recorded.
IFNc production
The effect that MOi had on the production of IFNc by CD8
was analyzed as follows. 1610
6 PBMC were co-incubated with
2610
5 MOi or MO during 18 h after which 1 ml GolgiPlug (BD)
was added and incubated for additional 5 h. Cells were harvested
and incubated in the presence of anti-CD8 PE (BD). They were
washed twice with PBS. Cells were suspended in Citofix/Citoperm
(BD) and washed with Perm/Wash. Then, cells were incubated
with anti- IFNc PE-Cy7 (BD) and washed twice on Perm/Wash.
Stained samples were suspended in PBS and analyzed by
multicolor flow cytometry.
IFNc production was also analyzed in the supernatants of the
cytotoxicity experiments using standard ELISA assays. In brief,
96-well microtitre plates (Costar, Corning, NY) were coated with
un-conjugated anti-IFNc (clone NIB42; 6 mg/ml; BD) capture
antibody in 100 mM Na2HPO4, pH 9.0 during 12 h at 4uC, and
blocked with PBS 0.1N NaOH, 0.5% casein, pH 7.4. Superna-
tants and hIFNc recombinant standard (R&D Systems, PR) were
incubated in RPMI/FBS 10% during 2 h at RT. hIFNc was
detected using biotinylated mouse Ab anti-hIFNc (clone 4S.B3,
0.5 mg/ml; BD) in 1% BSA, 0.05% Tween 20 using streptavidine
labeled with alkaline phosphatase (Life Technologies) and p-
nitrophenil phosphate (4 mg/ml, Life Technologies) as substrate.
Absorbance was read at 405 nm and IFNc concentration was
evaluated in the hIFNc recombinant standard curve. IFNc
concentration in every sample was calculated by lineal regression
using mean absorbance (average of three lectures by sample).
Detection limit was of ,15 pg/ml.
Stimulation with TLR2 ligands
Purified Leishmania mexicana LPG was obtained as previously
described (6). Commercial Pam3Cys-Ser-(Lys) 4 (PAM) was used as
control (EMC Microcollections GmbH, Tu ¨bingen, Germany).
Purified CD8 (1610
6) of DCL patients were stimulated with LPG
10 mg/ml or PAM 2 mM during 24 h. Cells were harvested, washed
twice, and used in cytotoxic assays. For proliferation and IFNc
production assays, 1610
5 pre-stimulated purified CD8 were co-
incubated with autologous 9610
5 PBMC and experiments were
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analyzed in non-stimulated and stimulated CD8 stained with anti-
CD8 PE, anti-CD3 CyChrome and anti-PD-1 FITC.
Data are expressed as mean 6 SEM and were tested using
Mann–Whitney U-test or Kruskall-Wallis test. A value of p,0.05
was considered statistically significant.
Figure 1. Cytotoxicity assay of CD8 against autologous Leishmania-infected macrophages (MOi). A) Culture dotplots (annexin V vs. 7AAD)
from MO, MOi, CD8/MO, and CD8/MOi of LCL and DCL patients. In top, the R1 region corresponds to the CD14
+ cells analyzed. The percentage of
annexin V
+ cells are shown. B) Analysis of flow cytometry assay. Cytotoxicity index (C.I.) was calculated from 10 LCL and 4 DCL patients. C) Analysis of
Cr
51 release assay. The % cytotoxicity was calculated from 9 LCL and 4 DCL patients. The bars show the mean of C.I. and % cytotoxicity. p was
obtained by the Mann-Whitney U test.
doi:10.1371/journal.pntd.0000871.g001
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CD8 cytotoxic against autologous MOi
In our previous report about cellular infiltrate in lesions of DCL
patients we described that the number of CD8 is importantly
reduced as compared to LCL patients [11]. The reduction in the
number of CD8 cells in lesions of DCL patients led us to analyze if
their cytotoxic effector function was also altered. Thus, we
analyzed the cytotoxic capacity of CD8 of LCL and DCL patients
against autologous MOi. The cytotoxic capacity was measured by
two methods: flow cytometry and
51Cr radiolabeling (Figure 1).
Prior to the cytotoxic experiments, the optimal CD8: MOi ratio
had been established as 10:1 (data not shown). The cytometry
assay revealed that patients with LCL had a C.I. of 19.8 as
compared to DCL patients, which showed a C.I. of 0.4, as
evidenced by double positive MOi dot blots (Figure 1A and 1B).
Additionally,
51Cr radiolabeling showed that the mean percentage
of cytotoxicity in LCL patients was 18% as compared to 3% en
DCL patients (Figure 1C). Thus, both methods showed a
significantly higher cytotoxicity of CD8 cells from LCL patients,
as compared to DCL patients, where cytotoxicity was almost null
(p,0.01). In order to rule out the possibility that CD8 death could
be responsible for the low cytotoxicity in DCL patients, we
analyzed CD8 expression of annexin V by flow cytometry assay
and found that CD8 do not undergo apoptosis when they are co-
incubated with MOi (data not shown).
CD8 cytotoxic mechanism against autologous MOi in LCL
CD8 T lymphocytes can exert cytotoxicity by two mechanisms:
granule exocytosis and death ligands. Granzyme B and FasL are
prominent executor molecules of these pathways [23]. To
determine the mechanism by which CD8 kill MOi, we measured
the expression of granzyme B and FasL, before and after cytotoxic
challenge with autologous MOi from LCL patients, which were
the only ones that had exhibited cytotoxic capacity. These assays
however were carried out in a CD8:MOi ratio of 1:1 since this
permitted better FACS analysis of protein expression in CD8 T
cells (Figure 2). Whereas FasL expression remained unchanged,
granzyme B expression decreased significantly (p,0.01) (Figure 2B)
after the cytotoxic challenge, which suggests that cytotoxicity is
mediated by cytotoxic granules.
Specific CD8 proliferation
As CD8 from DCL patients had shown a different cytotoxic
capacity with regard to LCL patients, we investigated other
functions that could be altered in the cells of both groups of
patients, such as specific proliferation of cells in contact with
Leishmania antigens. CD8 proliferation was evaluated in PBMC
cultures incubated with MOi. After 7 days of culture, a
CD8
+CFDA
low group was detected in LCL patients, formed by
cells that proliferated as a response to the stimulus of MOi
(Figure 3A). This group was not found in DCL patients, however,
a CD8
-CFDA
low group mainly consisting of CD3
+CD4
+ cells was
detected (data not shown). The proliferation of CD8 was only
evidenced when the cells were stimulated with MOi and the
difference between LCL and DCL patients was statistically
significant (% CD8
+CFDA
low MOi LCL =18.37+/27.1 vs
DCL =2.3+/21.5) (p,0.01) (Figure 3B). Stimulation with Con
A, as positive control, did not show differences in CD8
proliferation between LCL and DCL patients. This shows that
the lack of response in CD8 of DCL patients is specific towards
autologous MOi with Leishmania.
IFNc production by CD8
Another reported function of CD8 T cells in leishmaniasis is
IFNc production [10]. To examine if there are differences in the
Figure 2. Cytotoxic mechanism analysis. A) LCL patient CD8 were labeled for granzyme B or FasL in CD8 alone or co-cultured with MOi
(CD8+MOi) 1:1 for 4 h. R1 was analyzed from the CD8 vs FSC dotplot (top). Data are representative of 10 LCL patients. B) Mean fluorescence intensity
(MFI) for Granzyme B and FasL expression were analyzed in 10 LCL patients. T-student test was carried out between CD8 and CD8+MOi (p,0.01).
doi:10.1371/journal.pntd.0000871.g002
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when they are stimulated with autologous MOi, a 24-h in vitro
assay was performed after which lymphocytes were labeled for
intracellular IFNc. Only CD8 LCL patients showed response to
MOi (%CD8
+IFNc
+ DCL=1.8+/22.5 vs LCL =17.5+/23.9)
(p,0.01) (Figure 4A and 4B). This group of CD8
+IFNc
+ cells was
not detectable in DCL patients. None of the patients showed
CD8
+IL4
+ cells (data not shown). IFNc was also measured in the
supernatants of flow cytometric cytotoxic assays by ELISA. The
results show that IFNc was only detected in LCL patients (IFNc
CD8+MOi DCL =20 pg/ml +/24 vs LCL =241.8pg/ml +/2
137.1) (p,0.01) (Figure 4C). The lack of IFNc production by CD8
of DCL was specific towards Leishmania antigens since an appropriate
response was found to the non-specific mitotic stimulus PMA/
Ionomycin (Figure 4A and 4B).
Apoptosis in tissues
As in vitro CD8 cytotoxic assays showed an impaired function of
DCL cells as opposed to the robust response found in LCL patients
(Figure 1), we examined if biopsies of skin lesions of both groups of
patients showed any evidence of the different cytotoxicity between
both groups of patients We analyzed apoptotic cells through
TUNEL staining in skin biopsies of LCL and DCL patients
(Figure 5Aand B). The stain revealeda high proportion ofapoptotic
cells in tissues of 7 LCL patients (Figure 5A), which was significantly
higher as compared to 5 DCL patients (% TUNEL
+ LCL =63.4%
+/212.08 vs DCL =20.9% +/27.43) (p,0.01) (Figure 5B and
5D). DoublestaininginLCL patientsshowed that a largenumberof
apoptotic cells were MO (Figure 5C).
Evaluation of the TLR2 stimulus in CD8 of DCL patient
As CD8 from DCL patients had shown deficiencies in
Leishmania-specific cellular effector functions, we analyze if this
apparent ‘‘exhaustion’’ could be reversed by TLR2 stimulation, as
had been previously shown for other chronic diseases. We
examined cytotoxicity, antigen-specific proliferation and IFNc
production of CD8 from DCL patients, which had previously been
stimulated with LPG or Pam3Cys for 24 h. We observed a
recovery of the CD8 effector functions, including cytotoxicity,
IFNc production and proliferation (Figure 6A, B and C). The
stimulus with Pam3Cys induced higher levels in IFNc production
as compared to LPG. The response was highest when CD8 were
prestimulated with TLR2 ligands and challenged with MOi
(Figure 6B). Proliferation was also induced in CD8 cells although
they were not the only ones that responded to the stimulus, since a
population of CD8
- lymphocytes also proliferated (Figure 6C).
Again, Pam3Cys plus MOi could induce the highest response.
Since exhausted T cells have been shown to have increased
expression of programmed death-1 (PD-1) molecules, which could
be modified by TLR-9 ligand, we analyzed if PD-1 expression in
CD8 cells of DCL patients could be modified by TLR2 agonists.
We found that PD-1 expression in CD8
+ of DCL patients was
significantly reduced after stimulation with both TLR2 agonists,
LPG (p=0.02) and Pam3Cys (p=0.005) (Figure 6D).
Discussion
The protective immune response against Leishmania, amply
studied in mice, is mediated by macrophage-activating cytokines,
such as IFNc and IL-12 [5]. MO activation involves iNOS
expression and NO production, the latter being the most
important leishmanicidal agent [24]. In humans, IFNc production
and iNOS expression have also been directly associated with the
resolution of infection. Additionally, CD8 have been shown to play
an important role during Leishmania infection, both in humans as
well as in the mouse model. During the acute phase of the disease,
large numbers of CD8 have been described in the lesions as well as
in the peripheral blood of patients and they have also been
observed during the healing process [10]. Yet thus far, the
important role of CD8 in leishmaniasis has been related to their
IFNc production [25,26] and little is known of the protective
response mediated by the cytotoxicity exerted by these cells [27]. It
is additionally not clear, if these cytotoxic cells relate with disease
progression in patients with diffuse cutaneous leishmaniasis.
Previous studies of our group have shown that lesions of DCL
patients infected with L. mexicana harbor low numbers of CD8, as
compared to patients with LCL. Interestingly, the leishmanicidal
treatment of the DCL patients not only reduced the parasite load
but also led to an increase in CD8 during the healing process of
the skin lesions of these DCL patients [11]. To date, the
mechanism responsible for the reduced presence of CD8 in
lesions of DCL patients remains unclear. The marked response of
CD8 towards Leishmania parasites led us to analyze possible
functional differences between these cells from patients with LCL
and DCL. We therefore compared in vitro antigen-specific
proliferation, IFNc production and cytotoxicity of CD8 purified
from PBMC of both groups of patients against autologous
macrophages infected with Leishmania mexicana. Additionally we
analyzed tissue biopsies from both groups of patients for evidence
of cytotoxicity associated with apoptotic cells in the lesions.
Our data demonstrate that CD8 from DCL patients show a
significant reduction in their effector response when coincubated in
vitro with autologous macrophages infected with Leishmania
mexicana, as compared to patients with LCL. This diminished
cytotoxic response was also evidenced in lesions of both groups of
patients, since DCL patients showed significantly less apoptotic
cells as compared to LCL patients (Figure 5). Although not much
is known of the overall effector mechanisms of CD8 T cells in
human leishmaniasis, results obtained in the present work show
that both IFNc production, as well as cytotoxicity against
Leishmania-infected macrophages are hampered in DCL cells. It
is therefore feasible to speculate that CD8 cells play an important
role in the protective response of LCL patients against the
infection with Leishmania mexicana, based on our in vitro results,
together with the large number of apoptotic cells in the tissue
lesions of these patients. Although data on the expression of
apoptosis in skin lesions are scarce, our work is in accordance with
the literature, where apoptotic CD4 and CD8 T lymphocytes have
been described in lesions of LCL patients infected with L.
braziliensis, albeit cell death was attributed to hypersensitivity
towards Leishmania antigens, leading to activation-induced cell
death [28].
MO cell death in tissues could be due to Leishmania infection
and/or be a consequence of CD8 cytotoxic activity against
infected cells. The former mechanism is unlikely, since it has been
demonstrated that Leishmania can inhibit apoptotic mechanisms in
phagocytic cells [29,30,31,32]. The possible benefits derived from
cytotoxic CD8-induced apoptosis of the host cells infected with
Figure 3. Lymphocyte proliferation in LCL and DCL patients. A) CFDA-labeled PBMC were incubated with PBS (CNT), MOi or Con A [5 mM] for
seven days. CFDA
low cell percentages of total CD8 are shown. Representative dotplots from 8 LCL and 4 DCL patients are shown. B). Proliferation
analysis of CD8 from 8 LCL and 4 DCL patients, stimulated with PBS (black bars), MOi (white bars) and Con A (striped bars) are shown (p,0.01).
doi:10.1371/journal.pntd.0000871.g003
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4 h or with MOi during 24 h. Density diagrams of IFNc vs. CD8 from 10 LCL and 4 DCL patients are shown. B) CD8
+IFNc
+ percentage analysis from 10
LCL and 4 DCL patients are shown. C) ELISA results of IFNc production in supernatants of the co-incubation CD8-MOi from 9 LCL and 4 DCL patients
are shown (p,0.01).
doi:10.1371/journal.pntd.0000871.g004
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expansion of the specific immune response by providing novel
parasite antigens [10], as has described for M. tuberculosis [33].
Controversy remains regarding the route of activation of CD8
in leishmaniasis, since these cells require antigen presentation
through MHC class I to become activated. It is not known how
Leishmania antigens escape from the parasitophorous vacuole of
phagocytic cells into the cytosol to be degraded and transported
into the endoplasmic reticulum to be bound to the MHC I
molecule. One of the possible mechanisms described in dendritic
cells and macrophages is through cross-presentation and involves
the chaperone protein Sec61. Another mechanism of cross-
presentation of exogenous antigens could be through phagocytosis
of apoptotic bodies of infected cells by dendritic cells, which aids
the immune response by providing novel parasite antigens [10].
Good prognosis in patients with cutaneous leishmaniasis,
infected with L. major, has been associated with the expression of
granzyme B in tissue lesions [34]. In the present work, granzyme B
was also associated with the cytotoxic activity of CD8 of LCL
patients against MOi (Figure 2).
Since the presence of CD8 in the lesion has also been correlated
with recovery of Leishmania-infected patients [11], it is feasible that
lack of cytotoxicity of CD8 against MOi (Figure 1) can lead to
uncontrolled parasite spread in DCL patients. However the
functional efficacy of CD8 cells from patient tissues cannot be
comparatively analyzed with those from peripheral blood due to
the small size of lesions in LCL patients, which are often no larger
than 2 cm of diameter and therefore limit the amount of
lymphocytes available for functional experiments. Although we
cannot rule out functional differences between CD8 T cells from
lesions and those from peripheral blood, data in the literature have
suggested that immunological responses in vitro of peripheral blood
mononuclear cells closely mimic the immune response that occurs
in the whole organism [35,36].
One of the possible mechanisms underlying the reduced effector
capacity CD8 of DCL patients could be a functional ‘‘exhaustion’’
of these cells induced by a suppressive environment and antigen
persistence, as has recently been described [13]. Despite the small
number of DCL patients available for this study, due to the low
incidence of this form of the disease in Mexico, we found that CD8
of these patients showed certain functional and phenotypic
characteristics that resemble the exhaustion condition described
in some chronic viral infections [12]. ‘‘CD8 cell exhaustion’’ was
initially described in chronic LCMV infection in mice, in which
virus-specific CD8 persist, but lack effector functions [37]. In this
viral infection, CD8 clones are initially generated, but cytotoxicity
and proliferation are lost at an early stage, while IFNc persists for
a longer period [38]. Similar types of dysfunctions have been
described in human chronic infections and during cancer [12],
which suggests that chronic antigen stimulation alone suffices to
drive CD8 into exhaustion [13]. Recently in a murine model of L.
donovani infection, it has been describes that parasites initially
induce CD8 to divide and produce IFNc. However, CD8 rapidly
lose their effector functions and die as the infection progresses
[16]. Our present results suggest that the same phenomenon could
be occurring in DCL patients, which have a chronic intracellular
infection of more than 20 years evolution. These patients do not
present delayed cellular hypersensitivity toward specific Leishmania
antigens, as evidenced by their negative Montenegro skin test, nor
do they present a cell-mediated immunity towards the parasite [1]
(Figures. 1, 3 and 4). It must be noted that the lack of lympho-
proliferative response and the lack of IFNc production of CD8
from DCL patients was specific against Leishmania antigens, since
these cells preserved their capacity to respond to mitogens such as
Con A and PMA/Ionomycin (Figures. 3 and 4). These results
suggested that a functional exhaustion towards Leishmania mexicana
could be present in CD8 of DCL patients. ‘‘Exhausted’’ cells have
been shown to express higher levels of PD-1, among other
Figure 5. Apoptosis in LCL and DCL patient lesions. Frozen tissue sections of LCL (A) and DCL (B) were stained with TUNEL. Two representative
photographs are shown. C) Double staining of LCL patient tissue: TUNEL in peroxidase (brown), CD68 in phosphatase (red). Black arrows show
TUNEL
+ cells, red arrows show TUNEL
+ CD68
+ cells. D). Positive percentage analysis for TUNEL of 7 LCL and 5 DCL patients is shown. Three fields were
counted, 200 cells per field (p,0.05). Bar =20 mm.
doi:10.1371/journal.pntd.0000871.g005
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lymphocytes have focused on the use of anti-PD-L1 and PD-L2
antibodies, which prevent binding of T-cell PD-1 to the antigen-
presenting cell (APC) ligands PD-L1 and PD-L2 [16,17,38]. In
these studies, TCR and CD28 signals sufficed to rescue CD8 in
exhaustion, once PD-1 activity was blocked [17].
Recently, Wong and co-workers [18] demonstrated that peptide
vaccination in the presence of CpG ODN (TLR9 ligand) reduced
expression of PD-1 in mice. In addition to TLR9, another innate
receptor that has recently been described in CD8 is TLR2, which
triggers cellular activation similar to that of CD28 [39]. Therefore,
we hypothesized that TLR2 stimulation could reduce PD-1
expression and restore CD8 functional activity in DCL patients
against MOi. Since we had previously shown that LPG, the most
abundant surface molecule expressed on the Leishmania, is a TLR2
ligand capable of inducing IFNc production in human NK cells
[6], we therefore stimulated CD8 from DCL patients with LPG
and also with Pam3Cys, a recognized specific TLR2 ligands
(Figure 6A, B and C). We found that this preactivation could
increase CD8 cytotoxicity against MOi. Also, proliferation and
IFNc-producing CD8 could be detected when they were pre-
stimulated with LPG or Pam3Cys.
Due to a lack of knowledge of Leishmania-specific CD8 T cell
epitopes, antigen-specific CD8 responses in CL have not been
studied and therefore phenotypic characterization of possible CD8
exhaustion has not been feasible.
Although CD8 exhaustion has not been reported in patients
with leishmaniasis, our results on ‘‘functional exhaustion’’ is in
accordance with the literature since Joshi and coworkers could
demonstrate that L. donovani limits CD8 expansion and induces
functional exhaustion in an experimental model [16] which was
associated with increased PD-1 expression by Leishmania-specific
CD8. Our analysis also showed that PD-1 expression on CD8 of
DCL seems to be associated with functional exhaustion. We were
able to show that PD-1 expression on CD8 from DCL patients
could be reduced by stimulation with TLR2 ligands and that the
reduction correlated with functional restoration (Figure 6D).
These results suggest that stimulation by TLR2 could represent
a pathway hierarchically higher than PD-1. The TLR2 receptors
are constitutively expressed in memory T lymphocytes, both in
CD4 and CD8, and their activation leads to a co-stimulating signal
that induces cytokine production and proliferation [39]. More-
over, TLR2 - MyD88 signaling is a critical pathway in CD8 clonal
expansion and memory formation in vivo [19]. Additionally, TLR
signaling influences Treg function, in particular, Pam3Cys has
been shown to transiently reduce the expression of FoxP3
+ in Treg
cells and to suppress their activity [40]. Thus, TLR2 stimulation is
not only limited to innate immune responses, but also regulates the
adaptive immune response.
In conclusion, we here show that CD8 of DCL patients lack a
cytotoxic activity against autologous macrophages infected with
Leishmania mexicana and they present functional and phenotypic
characteristics of exhausted cells, possibly as a consequence of
chronic intracellular infection by Leishmania mexicana. We addi-
tionally present the first evidence in the literature that TLR2
stimulation can restore their effector functions. It remains to be
Figure 6. Effector functions of CD8 from DCL patients were
restored by pre-stimulation with TLR2 ligands. CD8 from DCL
peripheral blood were purified and incubated in L. mexicana LPG
[10 mg/ml] (CD8
L) or Pam3Cys [2 mg/ml] (CD8
P) for 24 h and washed
twice. CD8 were analyzed for: A) Cytotoxicity, B) IFNc production and C)
Proliferation. One representative of 3 DCL patients is shown. D) Analysis
of mean fluorescence intensity (MFI) for PD-1 expression on non-
stimulated (CNT), LPG or Pam3Cys-stimulated CD8 from 3 DCL patients
is shown (*p=0.02, **p=0.005).
doi:10.1371/journal.pntd.0000871.g006
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antigens is a cause or a consequence of the progressive infection of
DCL patients by Leishmania mexicana and if TLR2 induces
downregulation of PD-1 pathway. This finding not only broadens
our knowledge of the pathogenesis of the disease but will allow the
design of activators of CD8 from DCL patients, based on TLR2
stimulation of the immune response.
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